Heidy King-jones
See Remarks at Spyre Therapeutics, Inc. (SYRE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 40031,378 held (−1%) | $89.24 | $36K | -4.0% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 16,60514,773 held (−53%) | $90.35 | $1.5M | -5.2% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 7,2287,545 held (−49%) | $91.35 | $660K | -6.2% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,1005,445 held (−28%) | $92.70 | $195K | -7.6% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,6002,845 held (−48%) | $93.46 | $243K | -8.3% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 4,84525,999 held (−16%) | $86.40 | $419K | -0.8% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 16,5489,451 held (−64%) | $87.20 | $1.4M | -1.7% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 6,2063,245 held (−66%) | $88.17 | $547K | -2.8% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 4002,845 held (−12%) | $89.38 | $36K | -4.1% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 4002,845 held (−12%) | $90.00 | $36K | -4.8% |
- Sell
See Remarks Heidy King-jones sold $36K of SYRE at $89.24 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Heidy King-jones sold $1.5M of SYRE at $90.35 — cuts the stake by 53%; pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Heidy King-jones sold $660K of SYRE at $91.35 — cuts the stake by 49%; pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Heidy King-jones sold $195K of SYRE at $92.70 — cuts the stake by 28%; pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Heidy King-jones sold $243K of SYRE at $93.46 — cuts the stake by 48%; pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Heidy King-jones sold $419K of SYRE at $86.40 — pre-scheduled 10b5-1 plan sale.